SNAP Update and ResourcesActualización y recursos de SNAP
On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more
El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más
Transportation UpdateActualización de transporte
SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.
Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.
SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.
Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.
Prior Authorization Updates for Esketamine (Spravato) Effective May 1, 2025, for Texas Medicaid
Date: June 30, 2025
Attention: All Providers
Effective date: May 1, 2025
Call to action: The purpose of this communication is to inform providers that effective for dates of service on or after May 1, 2025, prior authorization criteria for esketamine (Spravato) will change.
Treatment Indications
Esketamine (Spravato) will also be indicated as monotherapy for adult clients who are 18 years of age or older with treatment-resistant depression.
Refer to the current Texas Medicaid Provider Procedures Manual (TMPPM), Outpatient Drug Services Handbook, subsection 6.46, “Esketamine (Spravato)” for additional indications for esketamine (Spravato).
Diagnosis Requirements
The following diagnosis codes for major depressive disorder will also be considered for prior authorization:
Diagnosis Codes
F0631
F0632
F0634
F3289
F32A
F333
F338
F341
F530
Next steps: Providers should refer to the current TMPPM, Outpatient Drug Services Handbook, subsection 6.46.1, “Prior Authorization,” for additional diagnosis codes that will be considered for prior authorization.
